131 related articles for article (PubMed ID: 2166278)
21. Y2 receptors for peptide YY and neuropeptide Y on dispersed chief cells from guinea pig stomach.
Singh G; Singh L; Raufman JP
Am J Physiol; 1992 Apr; 262(4 Pt 1):G756-62. PubMed ID: 1314499
[TBL] [Abstract][Full Text] [Related]
22. Identification and functional studies of a specific peptide YY-preferring receptor in dog adipocytes.
Castan I; Valet P; Voisin T; Quideau N; Laburthe M; Lafontan M
Endocrinology; 1992 Oct; 131(4):1970-6. PubMed ID: 1327725
[TBL] [Abstract][Full Text] [Related]
23. Expression of functional Y1 receptors for neuropeptide Y in human Ewing's sarcoma cell lines.
van Valen F; Winkelmann W; Jürgens H
J Cancer Res Clin Oncol; 1992; 118(7):529-36. PubMed ID: 1320624
[TBL] [Abstract][Full Text] [Related]
24. Reciprocal interactions between alpha 2-adrenoceptor agonist and neuropeptide Y binding sites in the nucleus tractus solitarius of the rat. A biochemic and autoradiographic analysis.
Härfstrand A; Fuxe K; Agnati L; Fredholm B
J Neural Transm; 1989; 75(2):83-99. PubMed ID: 2537374
[TBL] [Abstract][Full Text] [Related]
25. Neuropeptide Y receptor in vascular smooth muscle.
Shigeri Y; Mihara S; Fujimoto M
J Neurochem; 1991 Mar; 56(3):852-9. PubMed ID: 1847185
[TBL] [Abstract][Full Text] [Related]
26. Pharmacological characterization of (125)I-1229U91 binding to Y1 and Y4 neuropeptide Y/Peptide YY receptors.
Schober DA; Gackenheimer SL; Heiman ML; Gehlert DR
J Pharmacol Exp Ther; 2000 Apr; 293(1):275-80. PubMed ID: 10734179
[TBL] [Abstract][Full Text] [Related]
27. Neuropeptide Y receptor in pig spleen: binding characteristics, reduction of cyclic AMP formation and calcium antagonist inhibition of vasoconstriction.
Lundberg JM; Hemsén A; Larsson O; Rudehill A; Saria A; Fredholm BB
Eur J Pharmacol; 1988 Jan; 145(1):21-9. PubMed ID: 2832184
[TBL] [Abstract][Full Text] [Related]
28. Neuropeptide Y receptors and the inhibition of adenylate cyclase in the human frontal and temporal cortex.
Westlind-Danielsson A; Undén A; Abens J; Andell S; Bartfai T
Neurosci Lett; 1987 Feb; 74(2):237-42. PubMed ID: 3033554
[TBL] [Abstract][Full Text] [Related]
29. Localization of Y1 receptors for NPY and PYY on vascular smooth muscle cells in rat pancreas.
Sheikh SP; Roach E; Fuhlendorff J; Williams JA
Am J Physiol; 1991 Feb; 260(2 Pt 1):G250-7. PubMed ID: 1847590
[TBL] [Abstract][Full Text] [Related]
30. A comparison of the binding of [3H]proprionyl-neuropeptide Y to rat and human frontal cortical membranes.
Widdowson PS; Halaris AE
J Neurochem; 1990 Sep; 55(3):956-62. PubMed ID: 2384761
[TBL] [Abstract][Full Text] [Related]
31. Characterization of a new neuropeptide Y Y5 agonist radioligand: [125I][cPP(1-7), NPY(19-23), Ala31, Aib32, Gln34]hPP.
Dumont Y; Thakur M; Beck-Sickinger A; Fournier A; Quirion R
Neuropeptides; 2004 Aug; 38(4):163-74. PubMed ID: 15337369
[TBL] [Abstract][Full Text] [Related]
32. Neuropeptide Y and peptide YY inhibit adenylate cyclase activity in the rat striatum.
Westlind-Danielsson A; Andell S; Abens J; Bartfai T
Acta Physiol Scand; 1988 Mar; 132(3):425-30. PubMed ID: 2852438
[TBL] [Abstract][Full Text] [Related]
33. Development and characterization of a highly selective neuropeptide Y Y5 receptor agonist radioligand: [125I][hPP1-17, Ala31, Aib32]NPY.
Dumont Y; Thakur M; Beck-Sickinger A; Fournier A; Quirion R
Br J Pharmacol; 2003 Aug; 139(7):1360-8. PubMed ID: 12890716
[TBL] [Abstract][Full Text] [Related]
34. Peptide-YY and neuropeptide-Y inhibit vasoactive intestinal peptide-stimulated adenosine 3',5'-monophosphate production in rat small intestine: structural requirements of peptides for interacting with peptide-YY-preferring receptors.
Servin AL; Rouyer-Fessard C; Balasubramaniam A; Saint Pierre S; Laburthe M
Endocrinology; 1989 Feb; 124(2):692-700. PubMed ID: 2536315
[TBL] [Abstract][Full Text] [Related]
35. Localization of neuropeptide Y binding sites in the zona glomerulosa of the bovine adrenal gland.
Torda T; Cruciani RA; Saavedra JM
Neuroendocrinology; 1988 Aug; 48(2):207-10. PubMed ID: 2851754
[TBL] [Abstract][Full Text] [Related]
36. Characterization of axonally transported [125I]PYY binding sites in rat vagus nerve.
Corp ES; Smith GP
Brain Res; 1991 Jul; 553(1):175-9. PubMed ID: 1718539
[TBL] [Abstract][Full Text] [Related]
37. Human syncytiotrophoblast NPY receptors are located on BBM and activate PLC-to-PKC axis.
Robidoux J; Simoneau L; St-Pierre S; Ech-Chadli H; Lafond J
Am J Physiol; 1998 Mar; 274(3):E502-9. PubMed ID: 9530134
[TBL] [Abstract][Full Text] [Related]
38. Neuropeptide Y binding and inhibition of cAMP accumulation in human neuroepithelioma cells.
Lobaugh LA; Blackshear PJ
Am J Physiol; 1990 May; 258(5 Pt 1):C913-22. PubMed ID: 2159234
[TBL] [Abstract][Full Text] [Related]
39. Comparative structural requirements of brain neuropeptide Y binding sites and vas deferens neuropeptide Y receptors.
Martel JC; Fournier A; St-Pierre S; Dumont Y; Forest M; Quirion R
Mol Pharmacol; 1990 Oct; 38(4):494-502. PubMed ID: 2172766
[TBL] [Abstract][Full Text] [Related]
40. Characterization of neuropeptide Y receptors in rabbit kidney: preliminary comparisons with rat and human kidney.
Schachter M; Miles CM; Leys K; Sever PS
J Cardiovasc Pharmacol; 1987; 10 Suppl 12():S157-62. PubMed ID: 2455171
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
